TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04673110 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04673110 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT00444288 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04144127 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00313274 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00594295 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02071758 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT03253562 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03633019 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT00630591 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00162435 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT00162435 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT03264079 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03115502 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT03115502 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02685059 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01819285 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02332434 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04197453 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT01430104 — Surrogate Endpoint (SUR): Serum calcium
Study NCT01892345 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT03504826 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study NCT01382160 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00283686 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT02103257 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02661984 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01716819 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01690871 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01690871 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01690871 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT05528484 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04532294 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00653432 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00930202 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02828176 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03229174 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02280122 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT00203814 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT00203814 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study NCT00125398 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03030885 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT02643056 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02643056 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02643056 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT02643056 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02643056 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT02643056 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT06423248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00212381 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00838357 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00838357 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02869932 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00741585 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04118257 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00390026 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00654147 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06192810 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03846245 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03846245 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT03846245 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT03846245 — Predictive Biomarker (PRD): Small-inducible cytokine A11
Genes: CCL11; SCYA11
Study NCT03846245 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study NCT03846245 — Predictive Biomarker (PRD): TIMP2 mRNA
Genes: TIMP2
Study NCT03846245 — Predictive Biomarker (PRD): GDF11 mRNA
Genes: GDF11; BMP11
Study NCT04354428 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00119093 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02649829 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT03037645 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04220879 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study NCT00273533 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02078349 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study NCT02185391 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01561664 — Pharmacodynamic Biomarker (PDY): Interferon regulatory factor 3
Genes: IRF3
Study NCT01561664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01561664 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT01561664 — Predictive Biomarker (PRD): ABCE1 mRNA
Genes: ABCE1; RLI; RNASEL1; RNASELI; RNS4I; OK/SW-cl.40
Study NCT01561664 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01561664 — Predictive Biomarker (PRD): TLR2
Genes: TIL4; CD282
Study NCT01480739 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03114280 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03232164 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00431067 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00928876 — Safety Biomarker (SAF): Interleukin 1
Study NCT03619967 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT00243646 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01729884 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01729884 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00353860 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01147016 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01147016 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01147016 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00064779 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT01644201 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00732771 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00014092 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00014092 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01361061 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT03910920 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01482494 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT00619957 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00452712 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00908531 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02802046 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00608569 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03049709 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00627627 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00627627 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06047184 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06047184 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04601441 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04601441 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01535235 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03778489 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03355859 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02798354 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03501056 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT02562118 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00769327 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00769327 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00188084 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT02916277 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02916277 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01901146 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03985878 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03127098 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00113360 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT04003610 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT01371890 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04056767 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01918982 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01918982 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT01918982 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04616001 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02038270 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04133636 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT02690701 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03926468 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01339442 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01339442 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01339442 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04268719 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT00898092 — Predictive Biomarker (PRD): BAALC mRNA
Genes: BAALC
Study NCT01272583 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03550443 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT03668496 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01227629 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00056199 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00056199 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT02034123 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT06009185 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06009185 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01411787 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT00926978 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00717730 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02319369 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT01346956 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01027884 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01027884 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02792868 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT02792868 — Surrogate Endpoint (SUR): Serum calcium
Study NCT03399799 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT03157414 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05336604 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00859027 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00859027 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00144170 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01168700 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01168700 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03394638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04512079 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04512079 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03651388 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT01504802 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT04365244 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04365244 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04057924 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00777751 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT01913873 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03457337 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01822314 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03266822 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03266822 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03266822 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study NCT02450760 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00319267 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00898547 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01126047 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT01165762 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00361413 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT03202511 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT03202511 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT03202511 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01466257 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT04810728 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01589809 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT03276533 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03276533 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01541566 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00634816 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02370121 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04478500 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01261403 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01604993 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00221286 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02781740 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01122264 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT03751332 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT05171452 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02887482 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03025347 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT00270608 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00006417 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04920409 — Predictive Biomarker (PRD): NFKB1 mRNA
Genes: NFKB1
Study NCT02826720 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02826720 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02826720 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02634866 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00202527 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04239846 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04239846 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04171635 — Predictive Biomarker (PRD): Liver iron
Study NCT02047344 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00814437 — Predictive Biomarker (PRD): KISS1R mRNA
Genes: KISS1R; AXOR12; GPR54
Study NCT02818010 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04172090 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00586430 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04159090 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04023084 — Predictive Biomarker (PRD): PDE4A mRNA
Genes: PDE4A; DPDE2
Study NCT05075915 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03044600 — Predictive Biomarker (PRD): CDC73 mRNA
Genes: CDC73; C1orf28; HRPT2
Study NCT04496882 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03124459 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00123331 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00045942 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT00783978 — Predictive Biomarker (PRD): SFTPB mRNA
Genes: SFTPB; SFTP3
Study NCT00783978 — Predictive Biomarker (PRD): SFTPC mRNA
Genes: SFTPC; SFTP2
Study NCT00783978 — Predictive Biomarker (PRD): ABCA3 mRNA
Genes: ABCA3; ABC3
Study NCT01091961 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01091961 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03191149 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03172260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03001271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03143088 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04606381 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04606381 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04606381 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04606381 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT05145270 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03396289 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00729365 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00729365 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02310009 — Safety Biomarker (SAF): Interleukin 1
Study NCT03869385 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01146470 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00220233 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03046992 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00983333 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00419796 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02295683 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04233918 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04315467 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04821492 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00972465 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00972465 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04484350 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01583426 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04445389 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02198950 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT00802815 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00046670 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00614458 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00614458 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04898725 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01562028 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01562028 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01562028 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF